GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lotus Pharmaceutical Co Ltd (TPE:1795) » Definitions » 14-Day RSI

Lotus Pharmaceutical Co (TPE:1795) 14-Day RSI : 37.41 (As of Mar. 27, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Lotus Pharmaceutical Co 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2025-03-27), Lotus Pharmaceutical Co's 14-Day RSI is 37.41.

The industry rank for Lotus Pharmaceutical Co's 14-Day RSI or its related term are showing as below:

TPE:1795's 14-Day RSI is ranked better than
85.15% of 1084 companies
in the Drug Manufacturers industry
Industry Median: 47.94 vs TPE:1795: 37.41

Competitive Comparison of Lotus Pharmaceutical Co's 14-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Lotus Pharmaceutical Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Pharmaceutical Co's 14-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lotus Pharmaceutical Co's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Lotus Pharmaceutical Co's 14-Day RSI falls into.


';

Lotus Pharmaceutical Co  (TPE:1795) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lotus Pharmaceutical Co  (TPE:1795) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Lotus Pharmaceutical Co 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Lotus Pharmaceutical Co's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Lotus Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Song Ren Road, 17th Floor, No. 277, Xin Yi District, Taipei, TWN, 110
Lotus Pharmaceutical Co Ltd is engaged in the healthcare sector. The only reportable segment of the company is the Pharmaceuticals business segment, which engages mainly in the research and development, manufacturing and sales of pharmaceutical products. It has a geographic presence in the United States, Malta, Taiwan, and Others.

Lotus Pharmaceutical Co Headlines

No Headlines